The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Akers Biosciences gains US patent for disposable cartridge

Thu, 16th Feb 2017 08:44

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, has been granted a US patent for its wellness disposable markers.The US Patent and Trademark Office has given a patent for its proprietary cartridge for the optical scanning device used in the company's BreathScan Lync technology, a new bluetooth-enabled reading device from Akers Wellness which allows users to track the results of breath-based tests on their mobile.The patent covers the design of the disposable cartridge which contains the reagent for the detection of wellness markers and the unique form factor, optical lens as well as read elements and the unique 'U' shaped airflow pathway.Chief executive John J. Gormally said: "We believe Akers Bio's technology for rapidly analyzing biomarkers in breath condensate is ideally suited for tests in the expansive US health and wellness market. I am pleased that this latest patent has been allowed as it is essential that we have robust protection over our valuable intellectual property."Separately, the AIM-listed company said that it is ramping marketing for OxiChek, a disposable breath test to determine levels of oxidative stress in the body by measuring the levels of certain abundant free radicals, through its distributor Aero-Med to anti-aging, functional and integrative health and wellness treatment practitioners in the US.Akers Wellness is also in talks with potential distributors for the KetoChek test which determines if a person is in the optimal fat-burning state for weight loss, known as ketosis.Gormally said: "OxiChek is the first fully commercialized Akers Wellness test in which this cartridge is applied. We are pleased that initial sales of this test are being recorded and excited about the scope for ramping up sales through national television marketing initiatives and major tradeshow participation."

Related Shares

More News
8 Oct 2018 13:10

Akers Biosciences appoints chief executive after settling legal battle

(Sharecast News) - Akers Biosciences appointed Howard Yeaton as chief executive on Monday as the company reached a settlement in its legal dispute wit...

15 Aug 2018 08:04

Akers Biosciences profits hit over antigen difficulties

(Sharecast News) - Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid as...

3 Apr 2018 13:45

Akers Biosciences 2017 Revenue Rises But Loss Widens On Higher Costs

LONDON (Alliance News) - Akers Biosciences Inc on Tuesday said revenue grew in 2017, but its loss widened due to increased costs across the business.T...

16 Mar 2018 18:11

Akers Biosciences Nets USD49,000 From Warrants Exercise (ALLISS)

LONDON (Alliance News) - Akers Biosciences Inc, a developer of health screening and testing products, said Friday that it has netted USD48,750 from wa...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.